245
Views
0
CrossRef citations to date
0
Altmetric
Review

Managing complications of chronic pancreatitis: a guide for the gastroenterologist

ORCID Icon, , , , , , , , , , , & show all
Pages 1267-1283 | Received 03 Jul 2023, Accepted 08 Dec 2023, Published online: 18 Dec 2023

References

  • Whitcomb DC, Frulloni L, Garg P, et al. Chronic pancreatitis: an international draft consensus proposal for a new mechanistic definition. Pancreatology. 2016;16(2):218–224. doi: 10.1016/j.pan.2016.02.001
  • Lévy P, Barthet M, Mollard BR, et al. Estimation of the prevalence and incidence of chronic pancreatitis and its complications: a prospective survey in adults attending gastroenterologists in France. Gastroenterol Clin Biol. 2006;30(6–7):838–844. doi: 10.1016/S0399-8320(06)73330-9
  • Capurso G, Archibugi L, Pasquali P, et al. Prevalence of chronic pancreatitis: results of a primary care physician-based population study. Dig Liver Dis. 2017;49(5):535–539. doi: 10.1016/j.dld.2016.12.024
  • Machicado JD, Dudekula A, Tang G, et al. Period prevalence of chronic pancreatitis diagnosis from 2001–2013 in the commercially insured population of the United States. Pancreatology. 2019;19(6):813–818. doi: 10.1016/j.pan.2019.07.003
  • Conwell DL, Banks PA, Sandhu BS, et al. Validation of demographics, etiology, and risk factors for chronic pancreatitis in the USA: a report of the north American pancreas study (NAPS) group. Dig Dis Sci. 2017;62(8):2133–2140. doi: 10.1007/s10620-017-4621-z
  • Singh VK, Whitcomb DC, Banks PA, et al. Acute pancreatitis precedes chronic pancreatitis in the majority of patients: results from the NAPS2 consortium. Pancreatology. 2022;22(8):1091–1098. doi: 10.1016/j.pan.2022.10.004
  • Hansen SEJ, Nordestgaard BG, Langsted A. Smoking as the most important risk factor for chronic pancreatitis in the general population. Eur J Epidemiol. 2023;38(1):95–107.
  • Engjom T, Nordaas IK, Tjora E, et al. Aetiological risk factors are associated with distinct imaging findings in patients with chronic pancreatitis: a study of 959 cases from the Scandinavian Baltic pancreatic club (SBPC) imaging database. Pancreatology. 2021;21(4):688–697. doi: 10.1016/j.pan.2021.02.023
  • Whitcomb DC. Pancreatitis: TIGAR-O version 2 risk/etiology checklist with topic reviews, updates, and use primers. Clin Transl Gastroenterol. 2019;10:1–14. doi: 10.14309/ctg.0000000000000027
  • Hollenbach M, Capurso G. “Car body appearance and engine”: the morphology-function correlation in chronic pancreatitis. United Eur Gastroenterol J. 2022;10(4):361–362. doi: 10.1002/ueg2.12229
  • Cohen SM, Kent TS. Etiology, diagnosis, and modern management of chronic pancreatitis: a systematic review. JAMA Surg. 2023;158:652–661. doi: 10.1001/jamasurg.2023.0367
  • Nabi Z, Lakhtakia S. Endoscopic management of chronic pancreatitis. Dig Endosc. 2021;33(7):1059–1072. doi: 10.1111/den.13968
  • Löhr JM, Dominguez‐Munoz E, Rosendahl J, et al. United European Gastroenterology evidence‐based guidelines for the diagnosis and therapy of chronic pancreatitis (HaPaneu). United Eur Gastroenterol J. 2017;5(2):153–199. doi: 10.1177/2050640616684695
  • Moutinho-Ribeiro P, Costa-Moreira P, Caldeira A, et al. Endoscopic Ultrasound-Guided Celiac Plexus Interventions. GE Port J Gastroenterol. 2020;28(1):32–38. doi: 10.1159/000508293
  • Ratnayake CB, Bunn A, Pandanaboyana S, et al. Spinal cord stimulation for management of pain in chronic pancreatitis: a systematic review of efficacy and complications. Neuromodulation: Technol Neural Interface. 2020;23(1):19–25. doi: 10.1111/ner.13051
  • Haj-Mirzaian A, Patel BN, Fishman EK, et al. Value of multidisciplinary collaboration in acute and chronic pancreatitis. Abdom Radiol N Y. 2020;45(5):1458–1467. doi: 10.1007/s00261-019-02320-9
  • Dumonceau JM, Delhaye M, Tringali A, et al. Endoscopic treatment of chronic pancreatitis: European society of gastrointestinal Endoscopy (ESGE) guideline – updated August 2018. Endoscopy. 2019;51(2):179–193. doi: 10.1055/a-0822-0832
  • Kempeneers MA, Issa Y, Bruno MJ, et al. Cost-effectiveness of early surgery versus Endoscopy-first approach for painful chronic pancreatitis in the ESCAPE trial. Ann Surg. 2023;277(4):E878–E884. doi: 10.1097/SLA.0000000000005240
  • Issa Y, Kempeneers MA, Bruno MJ, et al. Effect of early surgery vs Endoscopy-first approach on pain in patients with chronic pancreatitis: the ESCAPE randomized clinical trial. JAMA. 2020;323(3):237–247. doi: 10.1001/jama.2019.20967
  • Dalsania R, Shah R, Rana S, et al. Endoscopic ultrasound-guided management of chronic pancreatitis. Curr Gastroenterol Rep. 2020;22(7):22. doi: 10.1007/s11894-020-00772-4
  • Van Wanrooij RLJ, Bronswijk M, Kunda R, et al. Therapeutic endoscopic ultrasound: European society of gastrointestinal Endoscopy (ESGE) technical review. Endoscopy. 2022;54(3):310–332. doi: 10.1055/a-1738-6780
  • van der Merwe SW, van Wanrooij RLJ, Bronswijk M, et al. Therapeutic endoscopic ultrasound: European society of gastrointestinal Endoscopy (ESGE) guideline. Endoscopy. 2022;54(2):185–205. doi: 10.1055/a-1717-1391
  • Kempeneers MA, Issa Y, Ali UA, et al. International consensus guidelines for surgery and the timing of intervention in chronic pancreatitis. Pancreatology. 2020;20(2):149–157. doi: 10.1016/j.pan.2019.12.005
  • Hu B, Sun B, Cai Q, et al. Asia-pacific consensus guidelines for endoscopic management of benign biliary strictures. Gastrointest Endosc. 2017;86(1):44–58. doi: 10.1016/j.gie.2017.02.031
  • Gandhi S, De La Fuente J, Murad MH, et al. Chronic pancreatitis is a risk factor for pancreatic cancer, and incidence increases with duration of disease: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2022;13(3):E00463. doi: 10.14309/ctg.0000000000000463
  • Mel Wilcox C, Gress T, Boermeester M, et al. International consensus guidelines on the role of diagnostic endoscopic ultrasound in the management of chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the international association of Pancreatology, the American pancreatic association, the Japan pancreas society, and European pancreatic club. Pancreatology. 2020;20(5):822–827. doi: 10.1016/j.pan.2020.05.025
  • Strand DS, Law RJ, Yang D, et al. AGA clinical practice update on the endoscopic approach to recurrent acute and chronic pancreatitis: expert review. Gastroenterology. 2022;163(4):1107–1114. doi: 10.1053/j.gastro.2022.07.079
  • Ramchandani M, Lakhtakia S, Costamagna G, et al. Fully covered self-expanding metal stent vs multiple plastic stents to treat benign biliary strictures secondary to chronic pancreatitis: a multicenter randomized trial. Gastroenterology. 2021;161(1):185–195. doi: 10.1053/j.gastro.2021.03.015
  • Giri S, Jearth V, Sundaram S. Covered self-expanding metal stents versus multiple plastic stents for benign biliary strictures: an updated meta-analysis of randomized controlled trials. Cureus. 2022;14. doi: 10.7759/cureus.24588
  • Gu Y, Wang L, Zhao L, et al. Effect of mobile phone reminder messages on adherence of stent removal or exchange in patients with benign pancreaticobiliary diseases: a prospectively randomized, controlled study. BMC Gastroenterol. 2016;16(1):1–6. doi: 10.1186/s12876-016-0522-4
  • Kleeff J, Whitcomb DC, Shimosegawa T, et al. Chronic pancreatitis. Nat Rev Dis Primer. 2017;3(1):1–18. doi: 10.1038/nrdp.2017.60
  • Surci N, Bassi C, Salvia R, et al. Long-term follow-up after surgery for chronic pancreatitis: a bicentric retrospective experience. Dig Surg. 2022;39(4):169–175. doi: 10.1159/000526263
  • Rana SS, Bhasin DK, Chandail VS, et al. Endoscopic balloon dilatation without fluoroscopy for treating gastric outlet obstruction because of benign etiologies. Surg Endosc. 2011;25(5):1579–1584. doi: 10.1007/s00464-010-1442-y
  • Chiu YC, Liang CM, Tam W, et al. The effects of endoscopic-guided balloon dilations in esophageal and gastric strictures caused by corrosive injuries. BMC Gastroenterol. 2013;13(1):9–13. doi: 10.1186/1471-230X-13-99
  • Heo J, Jung MK. Safety and efficacy of a partially covered self-expandable metal stent in benign pyloric obstruction. World J Gastroenterol. 2014;20(44):16721–16725. doi: 10.3748/wjg.v20.i44.16721
  • James TW, Greenberg S, Grimm IS, et al. EUS-guided gastroenteric anastomosis as a bridge to definitive treatment in benign gastric outlet obstruction. Gastrointest Endosc. 2020;91(3):537–542. doi: 10.1016/j.gie.2019.11.017
  • Van Wanrooij RLJ, Vanella G, Bronswijk M, et al. Endoscopic ultrasound-guided gastroenterostomy versus duodenal stenting for malignant gastric outlet obstruction: an international, multicenter, propensity score-matched comparison. Endoscopy. 2022;54(11):1023–1031. doi: 10.1055/a-1782-7568
  • Vanella G, Dell’anna G, Capurso G, et al. EUS-guided GastroEnterostomy for management of malignant gastric outlet obstruction: a prospective cohort study with matched comparison with enteral stenting. Gastrointest Endosc. 2023;98(3):337–347.e5. doi: 10.1016/j.gie.2023.04.2072
  • Banks PA, Bollen TL, Dervenis C, et al. Classification of acute pancreatitis—2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013;62(1):102–111. doi: 10.1136/gutjnl-2012-302779
  • Lerch MM, Stier A, Wahnschaffe U, et al. Pancreatic pseudocysts: observation, endoscopic drainage, or resection? Dtsch Arztebl Int. 2009;106:614–621. doi: 10.3238/arztebl.2009.0614
  • Varadarajulu S, Bang JY, Sutton BS, et al. Equal efficacy of endoscopic and surgical cystogastrostomy for pancreatic pseudocyst drainage in a randomized trial. Gastroenterology. 2013;145(3):583–590.e1. doi: 10.1053/j.gastro.2013.05.046
  • Bhakta D, de Latour R, Khanna L. Management of pancreatic fluid collections. Transl Gastroenterol Hepatol. 2022;7:17–17. doi: 10.21037/tgh-2020-06
  • Szakó L, Mátrai P, Hegyi P, et al. Endoscopic and surgical drainage for pancreatic fluid collections are better than percutaneous drainage: meta-analysis. Pancreatology. 2020;20(1):132–141. doi: 10.1016/j.pan.2019.10.006
  • Hocke M, Burmeister S, Braden B, et al. Controversies in EUS-guided treatment of walled-off necrosis. Endosc Ultrasound. 2022;11(6):442–457. doi: 10.4103/EUS-D-21-00189
  • Boxhoorn L, Verdonk RC, Besselink MG, et al. Comparison of lumen-apposing metal stents versus double-pigtail plastic stents for infected necrotising pancreatitis. Gut. 2023;72(1):66–72. doi: 10.1136/gutjnl-2021-325632
  • Guzmán-Calderón E, Chacaltana A, Díaz R, et al. Head-to-head comparison between endoscopic ultrasound guided lumen apposing metal stent and plastic stents for the treatment of pancreatic fluid collections: a systematic review and meta-analysis. J Hepato-Biliary-Pancreat Sci. 2022;29(2):198–211. doi: 10.1002/jhbp.1008
  • Bang JY, Navaneethan U, Hasan MK, et al. Non-superiority of lumen-apposing metal stents over plastic stents for drainage of walled-off necrosis in a randomised trial. Gut. 2019;68(7):1200–1209. doi: 10.1136/gutjnl-2017-315335
  • Vanella G, Bronswijk M, Van der Merwe SW, et al. Tailoring treatment to the circumstance: reasoning behind metal versus plastic drainage of pancreatic collections. Gut. 2023. doi: 10.1136/gutjnl-2023-330442gutjnl-2023-330442
  • Hamada T, Iwashita T, Saito T, et al. Disconnected pancreatic duct syndrome and outcomes of endoscopic ultrasound-guided treatment of pancreatic fluid collections: systematic review and meta-analysis. Dig Endosc. 2022;34(4):676–686. doi: 10.1111/den.14142
  • Arvanitakis M, Dumonceau JM, Albert J, et al. Endoscopic management of acute necrotizing pancreatitis: European Society of Gastrointestinal Endoscopy (ESGE) evidence-based multidisciplinary guidelines. Endoscopy. 2018;50(5):524–546. doi: 10.1055/a-0588-5365
  • Pawa R, Dorrell R, Russell G, et al. Long-term transmural drainage of pancreatic fluid collections with double pigtail stents following lumen-apposing metal stent placement improves recurrence-free survival in disconnected pancreatic duct syndrome. Dig Endosc. 2022;34(6):1234–1241. doi: 10.1111/den.14266
  • Chavan R, Nabi Z, Lakhtakia S, et al. Impact of transmural plastic stent on recurrence of pancreatic fluid collection after metal stent removal in disconnected pancreatic duct: a randomized controlled trial. Endoscopy. 2022;54(9):861–868. doi: 10.1055/a-1747-3283
  • Phillips ME, Hopper AD, Leeds JS, et al. Consensus for the management of pancreatic exocrine insufficiency: UK practical guidelines. BMJ Open Gastroenterol. 2021;8(1):1–17. doi: 10.1136/bmjgast-2021-000643
  • Gardner TB, Adler DG, Forsmark CE, et al. ACG Clinical Guideline: Chronic Pancreatitis. Am J Gastroenterol. 2020;115(3):322–339. doi: 10.14309/ajg.0000000000000535
  • Keller J. Human pancreatic exocrine response to nutrients in health and disease. Gut. 2005;54(suppl_6):1–28. doi: 10.1136/gut.2005.065946
  • Layer P, Yamamoto H, Kalthoff L, et al. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology. 1994;107(5):1481–1487. doi: 10.1016/0016-5085(94)90553-3
  • Capurso G, Traini M, Piciucchi M, et al. Exocrine pancreatic insufficiency: prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;12:129–139. doi: 10.2147/CEG.S168266
  • Domínguez-Muñoz JE, Iglesias-García J, Vilariño-Insua M, et al. 13C-mixed triglyceride breath test to assess oral enzyme substitution therapy in patients with chronic pancreatitis. Clin Gastroenterol Hepatol. 2007;5(4):484–488. doi: 10.1016/j.cgh.2007.01.004
  • Leeds JS, Oppong K, Sanders DS. The role of fecal elastase-1 in detecting exocrine pancreatic disease. Nat Rev Gastroenterol Hepatol. 2011;8(7):405–415. doi: 10.1038/nrgastro.2011.91
  • Vanga RR, Tansel A, Sidiq S, et al. Diagnostic performance of measurement of fecal elastase-1 in Detection of exocrine pancreatic insufficiency: systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2018;16(8):1220–1228.e4. doi: 10.1016/j.cgh.2018.01.027
  • Trang T, Chan J, Graham DY. Pancreatic enzyme replacement therapy for pancreatic exocrine insufficiency in the 21st century. World J Gastroenterol. 2014;20(33):11467–11485. doi: 10.3748/wjg.v20.i33.11467
  • Endres TM, Konstan MW. What is cystic fibrosis? JAMA. 2022;327(2):191. doi: 10.1001/jama.2021.23280
  • Middleton PG, Mall MA, Dřevínek P, et al. Elexacaftor–tezacaftor–ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med. 2019;381(19):1809–1819. doi: 10.1056/NEJMoa1908639
  • Sabharwal S, Lusman SS. CFTR modulators for the gastroenterologist. J Pediatr Gastroenterol Nutr. 2023;77(4):445–447. doi: 10.1097/MPG.0000000000003904
  • Ramsey ML, Li SS, Lara LF, et al. Cystic fibrosis transmembrane conductance regulator modulators and the exocrine pancreas: a scoping review. J Cyst Fibros. 2023;22(2):193–200. doi: 10.1016/j.jcf.2022.08.008
  • Capurso G, Signoretti M, Archibugi L, et al. Systematic review and meta-analysis: small intestinal bacterial overgrowth in chronic pancreatitis. United Eur Gastroenterol J. 2016;4(5):697–705. doi: 10.1177/2050640616630117
  • Phillips ME, Robertson MD, Hart KH, et al. Long-term effects of clinical interventions on nutritional status in patients with chronic pancreatitis - a systematic review. Clin Nutr ESPEN. 2022;48:178–185. doi: 10.1016/j.clnesp.2021.12.032
  • Stigliano S, Archibugi L, Signoretti M, et al. The baseline nutritional status assessed by MUST score has a low accuracy in predicting the risk of hospitalization during follow-up in patients with chronic pancreatitis: a cohort study: CP nutritional status and complications. Pancreatology. 2020;20(2):182–186. doi: 10.1016/j.pan.2019.12.012
  • Cederholm T, Jensen GL, Correia MITD, et al. GLIM criteria for the diagnosis of malnutrition – a consensus report from the global clinical nutrition community. Clin Nutr. 2019;38(1):1–9. doi: 10.1016/j.clnu.2018.08.002
  • Wiese ML, Gärtner S, von Essen N, et al. Malnutrition is highly prevalent in patients with chronic pancreatitis and characterized by loss of skeletal muscle mass but absence of impaired physical function. Front Nutr. 2022;9:1–12. doi: 10.3389/fnut.2022.889489
  • Gopi S, Qamar S, Singh N, et al. Malnutrition by GLIM criteria in chronic pancreatitis: prevalence, predictors, and its impact on quality of life. Pancreatology. 2022;22(3):367–373. doi: 10.1016/j.pan.2022.02.004
  • Oyebola T, Mavilakandy A, Stephenson JA, et al. Sarcopenia: an assessment into the prevalence and disease burden in chronic pancreatitis patients. J Frailty Sarcopenia Falls. 2023;8(1):38–43. doi: 10.22540/JFSF-08-038
  • Cruz-Jentoft AJ, Gonzalez MC, Prado CM. Sarcopenia ≠ low muscle mass. Eur Geriatr Med. 2023;14(2):225–228. doi: 10.1007/s41999-023-00760-7
  • Bundred J, Thakkar RG, Pandanaboyana S. Systematic review of sarcopenia in chronic pancreatitis: prevalence, impact on surgical outcomes, and survival. Expert Rev Gastroenterol Hepatol. 2022;16(7):665–672. doi: 10.1080/17474124.2022.2091544
  • Cruz-Jentoft AJ, Bahat G, Bauer J, et al. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. doi: 10.1093/ageing/afy169
  • da Silva BR, Gonzalez MC, Cereda E, et al. Exploring the potential role of phase angle as a marker of oxidative stress: a narrative review. Nutrition. 2022;93:111493. doi: 10.1016/j.nut.2021.111493
  • Olesen SS, Büyükuslu A, Køhler M, et al. Sarcopenia associates with increased hospitalization rates and reduced survival in patients with chronic pancreatitis. Pancreatology. 2019;19(2):245–251. doi: 10.1016/j.pan.2019.01.006
  • Ramai D, Facciorusso A, Maida M, et al. Prevalence of osteopathy in chronic pancreatitis: a systematic review and meta-analysis. Clin Transl Gastroenterol. 2023;14(8):e00623. doi: 10.14309/ctg.0000000000000623
  • Vujasinovic M, Nezirevic Dobrijevic L, Asplund E, et al. Low bone mineral density and risk for osteoporotic fractures in patients with chronic pancreatitis. Nutrients. 2021;13(7):1–13. doi: 10.3390/nu13072386
  • Cai F, Hu C, Chen CJ, et al. Vitamin D and pancreatitis: a narrative review of Current evidence. Nutrients. 2022;14(10):2113–2115. doi: 10.3390/nu14102113
  • Barkin JA, Barkin JS. Chronic pancreatitis and bone disease. J Clin Densitom. 2020;23(2):237–243. doi: 10.1016/j.jocd.2019.08.004
  • Zheng M, Gao R. Vitamin D: a potential star for treating chronic pancreatitis. Front Pharmacol. 2022;13:1–15. doi: 10.3389/fphar.2022.902639
  • Christakos S, Dhawan P, Verstuyf A, et al. Vitamin D: Metabolism, molecular mechanism of action, and pleiotropic effects. Physiol Rev. 2015;96(1):365–408. doi: 10.1152/physrev.00014.2015
  • Martínez-Moneo E, Stigliano S, Hedström A, et al. Deficiency of fat-soluble vitamins in chronic pancreatitis: a systematic review and meta-analysis. Pancreatology. 2016;16(6):988–994. doi: 10.1016/j.pan.2016.09.008
  • Binkley NC, Suttie JW. Vitamin K nutrition and osteoporosis. J Nutr. 1995;125(7):1812–1821. doi: 10.1093/jn/125.7.1812
  • Stigliano S, Waldthaler A, Martinez-Moneo E, et al. Vitamins D and K as factors associated with osteopathy in chronic pancreatitis: a prospective multicentre study (P-BONE study). Clin Transl Gastroenterol. 2018;9:197. doi: 10.1038/s41424-018-0066-8
  • Hoogenboom SA, Lekkerkerker SJ, Fockens P, et al. Systematic review and meta-analysis on the prevalence of vitamin D deficiency in patients with chronic pancreatitis. Pancreatology. 2016;16(5):800–806. doi: 10.1016/j.pan.2016.07.010
  • Duggan SN, Smyth ND, O’Sullivan M, et al. The prevalence of malnutrition and fat-soluble Vitamin deficiencies in chronic pancreatitis. Nutr Clin Pract. 2014;29(3):348–354. doi: 10.1177/0884533614528361
  • Duggan SN, Purcell C, Kilbane M, et al. An association between abnormal bone turnover, systemic inflammation, and osteoporosis in patients with chronic pancreatitis: a case-matched study. Am J Gastroenterol. 2015;110(2):336–345. doi: 10.1038/ajg.2014.430
  • Olesen SS, Poulsen JL, Vestergaard P, et al. Vitamin-D deficiency in patients with chronic pancreatitis – prevalence and pitfalls. Pancreatology. 2017;17(1):22–23. doi: 10.1016/j.pan.2016.10.007
  • Bang UC, Benfield T, Bendtsen F, et al. The risk of fractures among patients with cirrhosis or chronic pancreatitis. Clin Gastroenterol Hepatol. 2014;12(2):320–326. doi: 10.1016/j.cgh.2013.04.031
  • Haas S, Krins S, Knauerhase A, et al. Altered bone metabolism and bone density in patients with chronic pancreatitis and pancreatic exocrine insufficiency. JOP J Pancreas. 2015;16:58–62.
  • Arvanitakis M, Ockenga J, Bezmarevic M, et al. ESPEN guideline on clinical nutrition in acute and chronic pancreatitis. Clin Nutr. 2020;39(3):612–631. doi: 10.1016/j.clnu.2020.01.004
  • Kanakis A, Vipperla K, Papachristou GI, et al. Bone health assessment in clinical practice is infrequenty performed in patients with chronic pancreatitis. Pancreatology. 2020;20(6):1109–1114. doi: 10.1016/j.pan.2020.07.396
  • Valenciano CM-L, Bolado Concejo F, Marín Serrano E, et al. Prevalence of exocrine pancreatic insufficiency in patients with chronic pancreatitis without follow-up. PANCR-EVOL study. Gastroenterol Hepatol. 2018;41:77–86. doi: 10.1016/j.gastrohep.2017.08.002
  • Nøjgaard C, Bendtsen F, Becker U, et al. Danish patients with chronic pancreatitis have a four-fold higher mortality rate than the Danish population. Clin Gastroenterol Hepatol. 2010;8(4):384–390. doi: 10.1016/j.cgh.2009.12.016
  • Bang UC, Benfield T, Hyldstrup L, et al. Mortality, cancer, and comorbidities associated with chronic pancreatitis: a Danish nationwide matched-cohort study. Gastroenterology. 2014;146(4):989–994.e1. doi: 10.1053/j.gastro.2013.12.033
  • La Iglesia-Garcia De D, Vallejo-Senra N, Iglesias-Garcia J, et al. Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis. J Clin Gastroenterol. 2018;52(8):e63–e72. doi: 10.1097/MCG.0000000000000917
  • Pedrazzoli S, Pasquali C, Guzzinati S, et al. Survival rates and cause of death in 174 patients with chronic pancreatitis. J Gastrointest Surg. 2008;12(11):1930–1937. doi: 10.1007/s11605-008-0620-x
  • Thuluvath PJ, Imperio D, Nair S, et al. Chronic pancreatitis: long-term pain relief with or without surgery, cancer risk, and mortality. J Clin Gastroenterol. 2003;36(2):159–165. doi: 10.1097/00004836-200302000-00014
  • Murruste M, Kirsimägi Ü, Kase K, et al. Long-term survival, risk factors and causes of mortality in surgically treated chronic pancreatitis. Pancreatology. 2021;21(4):714–723. doi: 10.1016/j.pan.2021.03.003
  • Seicean A, Tantǎu M, Grigorescu M, et al. Mortality risk factors in chronic pancreatitis. J Gastrointestin Liver Dis. 2006;15(1):21–26.
  • Gullo L, Stella A, Labriola E, et al. Cardiovascular lesions in chronic pancreatitis - a prospective study. Dig Dis Sci. 1982;27(8):716–722. doi: 10.1007/BF01393767
  • Chung WS, Lin CL. Comorbid risks of deep vein thrombosis and pulmonary thromboembolism in patients with chronic pancreatitis: a nationwide cohort study. J Thromb Haemost. 2016;14(1):98–104. doi: 10.1111/jth.13195
  • Sung LC, Chang CC, Lin CS, et al. Risk of acute atherosclerotic cardiovascular disease in patients with acute and chronic pancreatitis. Sci Rep. 2021;11(1):1–7. doi: 10.1038/s41598-021-99915-4
  • Forouzandeh F, Salazar G, Patrushev N, et al. Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis. J Am Heart Assoc. 2014;3(6):1–12. doi: 10.1161/JAHA.114.001202
  • Steyers CM, Miller FJ. Endothelial dysfunction in chronic inflammatory diseases. Int J Mol Sci. 2014;15(7):11324–11349. doi: 10.3390/ijms150711324
  • de la Iglesia D, Vallejo-Senra N, López-López A, et al. Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: a prospective, longitudinal cohort study. J Gastroenterol Hepatol Aust. 2019;34(1):277–283. doi: 10.1111/jgh.14460
  • Schöttker B, Haug U, Schomburg L, et al. Strong associations of 25-hydroxyvitamin D concentrations with all-cause, cardiovascular, cancer, and respiratory disease mortality in a large cohort study. Am J Clin Nutr. 2013;97(4):782–793. doi: 10.3945/ajcn.112.047712
  • Nikolic S, Dugic A, Steiner C, et al. Chronic pancreatitis and the heart disease: still terra incognita? World J Gastroenterol. 2019;25(44):6561–6570. doi: 10.3748/wjg.v25.i44.6561
  • Marotta F, Tajiri H, Li ZL, et al. Pure pancreatic juice from patients with chronic pancreatitis has an impaired antibacterial activity. Int J Pancreatol. 1997;22(3):215–220. doi: 10.1007/BF02788387
  • Chonchubhair HM N, Bashir Y, Dobson M, et al. The prevalence of small intestinal bacterial overgrowth in non-surgical patients with chronic pancreatitis and pancreatic exocrine insufficiency (PEI). Pancreatology. 2018;18(4):379–385. doi: 10.1016/j.pan.2018.02.010
  • El Kurdi B, Babar S, El Iskandarani M, et al. Factors that affect prevalence of small intestinal bacterial overgrowth in chronic pancreatitis: a systematic review, meta-analysis, and meta-regression. Clin Transl Gastroenterol. 2019;10(9):1–12. doi: 10.14309/ctg.0000000000000072
  • Kumar K, Ghoshal UC, Srivastava D, et al. Small intestinal bacterial overgrowth is common both among patients with alcoholic and idiopathic chronic pancreatitis. Pancreatology. 2014;14(4):280–283. doi: 10.1016/j.pan.2014.05.792
  • Lee AA, Baker JR, Wamsteker EJ, et al. Small intestinal bacterial overgrowth is common in chronic pancreatitis and associates with diabetes, chronic pancreatitis severity, low zinc levels, and opiate use. Am J Gastroenterol. 2019;114(7):1163–1171. doi: 10.14309/ajg.0000000000000200
  • Besselink MG, van Santvoort HC, Buskens E, et al. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet. 2008;371(9613):651–659. doi: 10.1016/S0140-6736(08)60207-X
  • Tseng CW, Chen YT, Lin CL, et al. Association between chronic pancreatitis and pyogenic liver abscess: a nationwide population study. Curr Med Res Opin. 2017;33(3):505–510. doi: 10.1080/03007995.2016.1266312
  • Lai SW, Lin CL, Liao KF. Chronic pancreatitis correlates with increased risk of herpes zoster in a population-based retrospective cohort study. J Hepato-Biliary-Pancreat Sci. 2018;25(9):412–417. doi: 10.1002/jhbp.575
  • Adejumo AC, Adejumo KL, Pani LN. Risk and outcomes of clostridium difficile infection with chronic pancreatitis. Pancreas. 2019;48(8):1041–1049. doi: 10.1097/MPA.0000000000001380
  • Beas R, Riva-Moscoso A, Ribaudo I, et al. Prevalence of depression among patients with chronic pancreatitis: a systematic review and meta-analysis. Clin Res Hepatol Gastroenterol. 2023;47(5):102115. doi: 10.1016/j.clinre.2023.102115
  • Phillips AE, Faghih M, Drewes AM, et al. Psychiatric comorbidity in patients with chronic pancreatitis associates with pain and reduced quality of life. Am J Gastroenterol. 2020;115(12):2077–2085. doi: 10.14309/ajg.0000000000000782
  • Chen CH, Lin CL, Hsu CY, et al. A retrospective administrative database analysis of suicide attempts and completed suicide in patients with chronic pancreatitis. Front Psychiatry. 2018;9:1–11. doi: 10.3389/fpsyt.2018.00147
  • Le Cosquer G, Maulat C, Bournet B, et al. Pancreatic cancer in chronic pancreatitis: pathogenesis and diagnostic approach. Cancers (Basel). 2023;15(3):1–22. doi: 10.3390/cancers15030761
  • Buscail L, Bournet B, Cordelier P. Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer. Nat Rev Gastroenterol Hepatol. 2020;17(3):153–168. doi: 10.1038/s41575-019-0245-4
  • Al Mamun A, Suchi SA, Aziz MA, et al. Pyroptosis in acute pancreatitis and its therapeutic regulation. Apoptosis. 2022;27(7–8):465–481. doi: 10.1007/s10495-022-01729-w
  • Saiki Y, Jiang C, Ohmuraya M, et al. Genetic mutations of pancreatic cancer and genetically engineered mouse models. Cancers (Basel). 2022;14(1):1–20. doi: 10.3390/cancers14010071
  • Kirkegård J, Mortensen FV, Cronin-Fenton D. Chronic pancreatitis and pancreatic cancer risk: a systematic review and meta-analysis. Am J Gastroenterol. 2017;112(9):1366–1372. doi: 10.1038/ajg.2017.218
  • Klein AP. Pancreatic cancer epidemiology: understanding the role of lifestyle and inherited risk factors. Nat Rev Gastroenterol Hepatol. 2021;18(7):493–502. doi: 10.1038/s41575-021-00457-x
  • Hegyi P, Párniczky A, Lerch MM, et al. International consensus guidelines for risk factors in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the international association of Pancreatology, t. Pancreatology. 2020;20(4):579–585. doi: 10.1016/j.pan.2020.03.014
  • Greenhalf W, Lévy P, Gress T, et al. International consensus guidelines on surveillance for pancreatic cancer in chronic pancreatitis. Recommendations from the working group for the international consensus guidelines for chronic pancreatitis in collaboration with the international associatio. Pancreatology. 2020;20(5):910–918. doi: 10.1016/j.pan.2020.05.011
  • Howes N, Lerch MM, Greenhalf W, et al. Clinical and genetic characteristics of hereditary pancreatitis in Europe. Clin Gastroenterol Hepatol. 2004;2(3):252–261. doi: 10.1016/S1542-3565(04)00013-8
  • Grocock CJ, Rebours V, Delhaye MN, et al. The variable phenotype of the p.A16V mutation of cationic trypsinogen (PRSS1) in pancreatitis families. Gut. 2010;59(3):357–363. doi: 10.1136/gut.2009.186817
  • Muller N, Sarantitis I, Rouanet M, et al. Natural history of SPINK1 germline mutation related-pancreatitis. EBioMedicine. 2019;48:581–591. doi: 10.1016/j.ebiom.2019.09.032
  • Cazacu IM, Farkas N, Garami A, et al. Pancreatitis-associated genes and pancreatic cancer risk: a systematic review and meta-analysis. Pancreas. 2018;47(9):1078–1086. doi: 10.1097/MPA.0000000000001145
  • Goggins M, Overbeek KA, Brand R, et al. Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the international cancer of the pancreas screening (CAPS) consortium. Gut. 2020;69(1):7–17. doi: 10.1136/gutjnl-2019-319352
  • Capurso G, Paiella S, Carrara S, et al. Italian registry of families at risk of pancreatic cancer: AISP familial pancreatic cancer study group. Dig Liver Dis. 2020;52(10):1126–1130. doi: 10.1016/j.dld.2020.07.027
  • Luo G, Fan Z, Cheng H, et al. New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer. Pancreatology. 2018;18(8):971–976. doi: 10.1016/j.pan.2018.08.003
  • Boyd LNC, Ali M, Leeflang MMG, et al. Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: a meta-analysis of aggregate and individual participant data. eClinicalmedicine. 2023;55:1–13. doi: 10.1016/j.eclinm.2022.101747
  • Brand RE, Persson J, Bratlie SO, et al. Detection of early-stage pancreatic ductal adenocarcinoma from blood samples: results of a multiplex biomarker signature validation study. Clin Transl Gastroenterol. 2022;13(3):E00468. doi: 10.14309/ctg.0000000000000468
  • Kim J, Bamlet WR, Oberg AL, et al. Detection of early pancreatic ductal adenocarcinoma with thrombospondin-2 and CA19-9 blood markers. Sci Transl Med. 2017;9(398):eaah5583. doi: 10.1126/scitranslmed.aah5583
  • Mahajan UM, Oehrle B, Sirtl S, et al. Independent Validation and Assay Standardization of Improved Metabolic Biomarker Signature to Differentiate Pancreatic Ductal Adenocarcinoma From Chronic Pancreatitis. Gastroenterology. 2022;163(5):1407–1422. doi: 10.1053/j.gastro.2022.07.047
  • Monaghan B, Monaghan A, Ul Ain Q, et al. Significantly lower physical activity participation in individuals with chronic pancreatitis compared to controls: an exploratory study of objectively assessed physical activity levels. Dig Surg. 2023;40(1–2):69–75. doi: 10.1159/000530543
  • Yoh K, Nishikawa H, Enomoto H, et al. Effect of exercise therapy on sarcopenia in pancreatic cancer: a study protocol for a randomised controlled trial. BMJ Open Gastroenterol. 2018;5(1):1–5. doi: 10.1136/bmjgast-2017-000194
  • Olesen SS, Nøjgaard C, Poulsen JL, et al. Chronic pancreatitis is characterized by distinct complication clusters that associate with etiological risk factors. Am J Gastroenterol. 2019;114(4):656–664. doi: 10.14309/ajg.0000000000000147

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.